Literature DB >> 1552113

Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile.

A M Lincoff1, J J Popma, S G Ellis, J A Hacker, E J Topol.   

Abstract

To assess the clinical, angiographic and procedural correlates of outcome after abrupt vessel closure during coronary angioplasty, results were analyzed of 109 patients (8.3%) who had abrupt vessel closure during 1,319 consecutive coronary angioplasty procedures performed between July 1, 1988 and June 30, 1990. These 109 patients had a mean age of 59 +/- 11 years; 63% were male, 57% had had a prior myocardial infarction and 61% had multivessel disease. Coronary angioplasty was performed in the settings of acute myocardial infarction (14%), recent myocardial infarction (36%), unstable angina (34%) and stable ischemia (29%). Abrupt vessel closure occurred at a median of 27 min (range 0 min to 5 days) from the first balloon inflation. By angiographic criteria, thrombus or coronary dissection was identified in 20% and 28% of cases, respectively; both thrombus and dissection were present in 7% of closures, and 45% were due to indeterminate mechanisms. Successful reversal of abrupt vessel closure, defined as restoration of normal Thrombolysis In Myocardial Infarction (TIMI) grade 3 flow without resultant Q wave myocardial infarction, emergency bypass surgery or death, was achieved in 47 patients (43%). By hierarchal analysis, the incidence of death, emergency coronary bypass surgery, Q wave and non-Q wave myocardial infarction was 8%, 20%, 9% and 11%, respectively. Univariate analysis using 23 clinical, morphologic and procedural variables demonstrated that successful outcome after abrupt closure was associated with prolonged balloon inflations (greater than 120 s) (odds ratio = 6.87, p less than 0.001), unstable angina (odds ratio = 2.37, p = 0.034) and placement of an intracoronary stent (odds ratio = 5.33, p = 0.062). By multivariate analysis, independent correlates of successful outcome were prolonged balloon inflations (odds ratio = 5.11, p = 0.001) and intracoronary stenting (odds ratio = 4.37, p = 0.049). Thus, although prolonged balloon inflations and intracoronary stents may improve outcome after abrupt vessel closure, the cumulative risk of morbidity or mortality remains significant and mandates investigation into improved strategies for its prevention and treatment.

Entities:  

Mesh:

Year:  1992        PMID: 1552113     DOI: 10.1016/0735-1097(92)90272-o

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  30 in total

Review 1.  Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors.

Authors:  M T Roe; D J Moliterno
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

2.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

3.  Antithrombotic Therapy during Percutaneous Coronary Intervention.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

4.  In vitro bleeding test with PFA-100-aspects of controlling individual acetylsalicylic acid induced platelet inhibition in patients with cardiovascular disease.

Authors:  A J Peters; M Borries; F Gradaus; T W Jax; F C Schoebel; B E Strauer
Journal:  J Thromb Thrombolysis       Date:  2001-12       Impact factor: 2.300

Review 5.  A guide to drug use during percutaneous coronary intervention.

Authors:  Joseph K Choo; John J Young; Dean J Kereiakes
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Platelet Glycoprotein IIb/IIIa Integrin Blockade in Coronary Artery Disease: Current State of the Art.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 7.  Recent advances in primary percutaneous intervention for acute myocardial infarction.

Authors:  E J Smith; A Mathur; M T Rothman
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

Review 8.  Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions.

Authors:  Pitchaiah Mandava; Perumal Thiagarajan; Thomas A Kent
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  Coronary artery stents.

Authors:  A J Stewart; D J Coltart
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

10.  Temporary stent as a bail-out device during percutaneous transluminal coronary angioplasty: preliminary clinical experience.

Authors:  J S Gibbs; U Sigwart; N P Buller
Journal:  Br Heart J       Date:  1994-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.